A comparative analysis of each individual sample between the control and drug-treated groups showed DEG enrichment in similar canonical pathways, including GP6 signaling, hepatic fibrosis, and osteoarthritis pathways (Table S5). This evidence concerns the gene GP6 and Hepatic fibrosis.